These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 32954930)
1. An accelerated surface-mediated stress assay of antibody instability for developability studies. Kopp MRG; Wolf Pérez AM; Zucca MV; Capasso Palmiero U; Friedrichsen B; Lorenzen N; Arosio P MAbs; 2020; 12(1):1815995. PubMed ID: 32954930 [TBL] [Abstract][Full Text] [Related]
2. A Nanoparticle-Based Assay To Evaluate Surface-Induced Antibody Instability. Kopp MRG; Capasso Palmiero U; Arosio P Mol Pharm; 2020 Mar; 17(3):909-918. PubMed ID: 31917582 [TBL] [Abstract][Full Text] [Related]
3. An alternative assay to hydrophobic interaction chromatography for high-throughput characterization of monoclonal antibodies. Estep P; Caffry I; Yu Y; Sun T; Cao Y; Lynaugh H; Jain T; Vásquez M; Tessier PM; Xu Y MAbs; 2015; 7(3):553-61. PubMed ID: 25790175 [TBL] [Abstract][Full Text] [Related]
4. A novel screening method to assess developability of antibody-like molecules. Kohli N; Jain N; Geddie ML; Razlog M; Xu L; Lugovskoy AA MAbs; 2015; 7(4):752-8. PubMed ID: 25961854 [TBL] [Abstract][Full Text] [Related]
5. Developability Assessment of Engineered Monoclonal Antibody Variants with a Complex Self-Association Behavior Using Complementary Analytical and in Silico Tools. Shan L; Mody N; Sormani P; Rosenthal KL; Damschroder MM; Esfandiary R Mol Pharm; 2018 Dec; 15(12):5697-5710. PubMed ID: 30395473 [TBL] [Abstract][Full Text] [Related]
6. High throughput cross-interaction measures for human IgG1 antibodies correlate with clearance rates in mice. Kelly RL; Sun T; Jain T; Caffry I; Yu Y; Cao Y; Lynaugh H; Brown M; Vásquez M; Wittrup KD; Xu Y MAbs; 2015; 7(4):770-7. PubMed ID: 26047159 [TBL] [Abstract][Full Text] [Related]
7. High-throughput screening for developability during early-stage antibody discovery using self-interaction nanoparticle spectroscopy. Liu Y; Caffry I; Wu J; Geng SB; Jain T; Sun T; Reid F; Cao Y; Estep P; Yu Y; Vásquez M; Tessier PM; Xu Y MAbs; 2014; 6(2):483-92. PubMed ID: 24492294 [TBL] [Abstract][Full Text] [Related]
8. Application of Affinity-Capture Self-Interaction Nanoparticle Spectroscopy in Predicting Protein Stability, Especially for Co-Formulated Antibodies. Zhou M; Yan Z; Li H; Liu X; Sun P Pharm Res; 2021 Apr; 38(4):721-732. PubMed ID: 33754257 [TBL] [Abstract][Full Text] [Related]
9. Differences in human IgG1 and IgG4 S228P monoclonal antibodies viscosity and self-interactions: Experimental assessment and computational predictions of domain interactions. Lai PK; Ghag G; Yu Y; Juan V; Fayadat-Dilman L; Trout BL MAbs; 2021; 13(1):1991256. PubMed ID: 34747330 [TBL] [Abstract][Full Text] [Related]
10. Separating clinical antibodies from repertoire antibodies, a path to in silico developability assessment. Negron C; Fang J; McPherson MJ; Stine WB; McCluskey AJ MAbs; 2022; 14(1):2080628. PubMed ID: 35771588 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in silico assessment of the developability of a designed monoclonal antibody library. Wolf Pérez AM; Sormanni P; Andersen JS; Sakhnini LI; Rodriguez-Leon I; Bjelke JR; Gajhede AJ; De Maria L; Otzen DE; Vendruscolo M; Lorenzen N MAbs; 2019; 11(2):388-400. PubMed ID: 30523762 [TBL] [Abstract][Full Text] [Related]
12. Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries. Azevedo Reis Teixeira A; Erasmus MF; D'Angelo S; Naranjo L; Ferrara F; Leal-Lopes C; Durrant O; Galmiche C; Morelli A; Scott-Tucker A; Bradbury ARM MAbs; 2021; 13(1):1980942. PubMed ID: 34850665 [TBL] [Abstract][Full Text] [Related]
13. Ultradilute Measurements of Self-Association for the Identification of Antibodies with Favorable High-Concentration Solution Properties. Starr CG; Makowski EK; Wu L; Berg B; Kingsbury JS; Gokarn YR; Tessier PM Mol Pharm; 2021 Jul; 18(7):2744-2753. PubMed ID: 34105965 [TBL] [Abstract][Full Text] [Related]
14. Discovery of highly soluble antibodies prior to purification using affinity-capture self-interaction nanoparticle spectroscopy. Wu J; Schultz JS; Weldon CL; Sule SV; Chai Q; Geng SB; Dickinson CD; Tessier PM Protein Eng Des Sel; 2015 Oct; 28(10):403-14. PubMed ID: 26363633 [TBL] [Abstract][Full Text] [Related]
15. Biophysical and Sequence-Based Methods for Identifying Monovalent and Bivalent Antibodies with High Colloidal Stability. Alam ME; Geng SB; Bender C; Ludwig SD; Linden L; Hoet R; Tessier PM Mol Pharm; 2018 Jan; 15(1):150-163. PubMed ID: 29154550 [TBL] [Abstract][Full Text] [Related]
16. Early developability screen of therapeutic antibody candidates using Taylor dispersion analysis and UV area imaging detection. Lavoisier A; Schlaeppi JM MAbs; 2015; 7(1):77-83. PubMed ID: 25514497 [TBL] [Abstract][Full Text] [Related]
17. Measurements of Monoclonal Antibody Self-Association Are Correlated with Complex Biophysical Properties. Geng SB; Wittekind M; Vigil A; Tessier PM Mol Pharm; 2016 May; 13(5):1636-45. PubMed ID: 27045771 [TBL] [Abstract][Full Text] [Related]